Prinston Pharmaceutical was hit with a patent infringement lawsuit Friday in Delaware District Court arising from the company’s efforts to obtain FDA approval to manufacture doxycycline capsules. The complaint was filed by Morris, Nichols, Arsht & Tunnell and King & Spalding on behalf of Galderma Laboratories and TCD Royalty Sub LP, which assert patents associated with Oracea-brand doxycycline capsules. Counsel have not yet appeared for the defendant. The case is 1:22-cv-01166, Galderma Laboratories, L.P. et al v. Prinston Pharmaceutical Inc.

This suit was surfaced by Law.com Radar, a source for high-speed legal news and litigation updates personalized to your practice. Law.com Radar publishes daily updates on just-filed federal cases like this one. Click here to get started and be first to know about new suits in your region, practice area or client sector. Read the complaint here: